Related Experiment Video
Updated: May 28, 2026
05:51
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
Behavioral disturbances in Parkinson's disease.
1Assistant Professor, Psychiatry and Neurology, University of Maryland, School of Medicine, Movement Disorders Division, Department of Neurology, Baltimore, Md, USA.
Dialogues in Clinical Neuroscience
|October 29, 2011
Summary
Parkinson's disease (PD) management requires addressing both motor symptoms and behavioral changes like depression, anxiety, and hallucinations. Effective treatment of these behavioral aspects significantly enhances patient quality of life.
Area of Science:
- Neurology
- Psychiatry
- Neuroscience
Background:
- Parkinson's disease (PD) presents complex challenges beyond motor deficits.
- Patients with PD experience a high prevalence of psychiatric conditions, including depression and anxiety, potentially linked to neuropathology.
- Medication-induced hallucinations and cognitive impairment are common in PD patients.
Purpose of the Study:
- To highlight the complexity of Parkinson's disease (PD) treatment.
- To emphasize the importance of managing behavioral changes in PD patients.
- To underscore the need to address behavioral effects of PD interventions, including surgical options.
Main Methods:
- Literature review on PD symptomatology and treatment.
- Analysis of psychiatric comorbidities in PD.
- Examination of behavioral effects associated with PD therapies.
Main Results:
- Behavioral symptoms significantly impact PD patients' function and quality of life.
- Dopaminergic agents can cause medication-related hallucinations.
- Surgical interventions like deep brain stimulation require careful consideration of behavioral outcomes.
Conclusions:
- Comprehensive management of Parkinson's disease (PD) necessitates addressing both motor and behavioral symptoms.
- Psychiatric and cognitive issues are integral to PD care.
- Future research and clinical practice must integrate behavioral assessments into PD treatment strategies, especially with advancing surgical techniques.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:30Positive Symptoms of Schizophrenia: Hallucinations and Delusions
Schizophrenia is a complex mental health disorder that can manifest with various positive symptoms, including thought, movement, and behavior disorders. These symptoms significantly disrupt cognitive and motor functions, leading to profound effects on an individual's ability to engage with the world.
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes loosely...
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes loosely...